What are tirzepatide side effects week by week?

The General Pattern

Tirzepatide side effects are largely dose-dependent and time-dependent. The typical pattern repeats at each dose escalation:

• Week 1–2 of new dose: GI side effects peak
• Week 3–4: Most patients stabilize
• Next escalation: Pattern repeats, usually more mildly

Patients who titrate slowly tend to have milder side effects than those who push through on schedule regardless of how they feel.

Week 1–2 (Initiation at 2.5 mg)

• Mild nausea — often the first sign the drug is working
• Decreased appetite — starts within days
• Earlier fullness at meals
• Possible mild fatigue — often related to reduced caloric intake
• Rare: mild headache

2.5 mg is not considered therapeutic — it's the initiation dose for tolerability assessment.

Week 3–4 (Still on 2.5 mg or Moving to 5 mg)

• Initial nausea typically resolves
• Eating patterns adjust — smaller meals feel natural
• First noticeable weight loss
• If escalating to 5 mg in week 5: brief return of nausea common

Week 5–8 (5 mg)

5 mg is where most patients start seeing meaningful therapeutic effect. Side effects in this window:

• Nausea returns briefly with escalation, then stabilizes
• Constipation emerges in many patients during this phase
• Vomiting possible but less common than nausea
• Diarrhea in a minority of patients (opposite pattern)
• Fatigue as caloric intake adjusts

Support measures: adequate fluids, fiber, gentle activity. Magnesium supplementation helps constipation for some patients.

Week 9–12 (7.5 mg)

• Sulfur burps — egg-like taste, characteristic of GLP-1/GIP drugs, emerges in some patients
• Acid reflux can appear or worsen
• Constipation may persist
• Weight loss continues at typical 1–1.5% of body weight per week

Sulfur burps often respond to simethicone, activated charcoal, or dietary adjustment (reducing sulfur-rich foods like eggs, cruciferous vegetables, garlic for a few days).

Week 13–16 (10 mg — Common Maintenance Dose)

Most patients stabilize at 10 mg. If you're tolerating well and progressing on weight loss, you may stay here long-term. Side effects typically stabilize:

• Nausea usually mild or absent
• Constipation either resolves or becomes manageable with fiber/fluids
• Energy returns as metabolism adapts
• Appetite stays reduced but stable

Week 17+ (12.5 mg and 15 mg)

Higher doses reintroduce GI side effects, typically milder than at initiation because your GI tract has adapted. Still common:

• Brief return of nausea at each escalation
• Worsened constipation
• Increased satiety — some patients struggle to eat enough protein

Symptoms That Warrant Pausing or Contacting Your Provider

• Severe persistent abdominal pain — rule out pancreatitis
• Vomiting preventing oral intake — dehydration risk
• Right upper quadrant pain — gallbladder evaluation
• Severe constipation with abdominal distension
• Heart palpitations or chest pain
• Vision changes in diabetic patients
• Severe hypoglycemia if on insulin or sulfonylurea

Support Measures That Help

• Small, frequent meals instead of large ones
• Adequate fluid intake (2–3 liters/day)
• High-fiber foods or psyllium husk for constipation
• Protein prioritization (1.2–1.6 g/kg/day) for lean mass preservation
• Gentle walking for GI motility
• Ginger tea for nausea
• Magnesium citrate 200–400 mg at night for constipation

See the tirzepatide guide. Related: tirzepatide cost without insurance, tirzepatide dosage chart.